Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre: A qualitative, cognitive task analysis

Nervana Elkhadragy, Amanda P. Ifeachor, Julie B. Diiulio, Karen J. Arthur, Michael Weiner, Laura G. Militello, Peter A. Glassman, Alan J. Zillich, Alissa L. Russ

Research output: Contribution to journalArticle

Abstract

Background Many studies identify factors that contribute to renal prescribing errors, but few examine how healthcare professionals (HCPs) detect and recover from an error or potential patient safety concern. Knowledge of this information could inform advanced error detection systems and decision support tools that help prevent prescribing errors. Objective To examine the cognitive strategies that HCPs used to recognise and manage medication-related problems for patients with renal insufficiency. Design HCPs submitted documentation about medication-related incidents. We then conducted cognitive task analysis interviews. Qualitative data were analysed inductively. Setting Inpatient and outpatient facilities at a major US Veterans Affairs Medical Centre. Participants Physicians, nurses and pharmacists who took action to prevent or resolve a renal-drug problem in patients with renal insufficiency. Outcomes Emergent themes from interviews, as related to recognition of renal-drug problems and decision-making processes. Results We interviewed 20 HCPs. Results yielded a descriptive model of the decision-making process, comprised of three main stages: detect, gather information and act. These stages often followed a cyclical path due largely to the gradual decline of patients' renal function. Most HCPs relied on being vigilant to detect patients' renal-drug problems rather than relying on systems to detect unanticipated cues. At each stage, HCPs relied on different cognitive cues depending on medication type: for renally eliminated medications, HCPs focused on gathering renal dosing guidelines, while for nephrotoxic medications, HCPs investigated the need for particular medication therapy, and if warranted, safer alternatives. Conclusions Our model is useful for trainees so they can gain familiarity with managing renal-drug problems. Based on findings, improvements are warranted for three aspects of healthcare systems: (1) supporting the cyclical nature of renal-drug problem management via longitudinal tracking mechanisms, (2) providing tools to alleviate HCPs' heavy reliance on vigilance and (3) supporting HCPs' different decision-making needs for renally eliminated versus nephrotoxic medications.

Original languageEnglish (US)
Article numbere027439
JournalBMJ Open
Volume9
Issue number5
DOIs
StatePublished - May 1 2019
Externally publishedYes

Fingerprint

United States Department of Veterans Affairs
Ambulatory Care
Renal Insufficiency
Inpatients
Decision Making
Delivery of Health Care
Kidney
Pharmaceutical Preparations
Cues
Interviews
Patient Safety
Pharmacists
Documentation
Outpatients
Nurses
Guidelines

Keywords

  • health and safety
  • medical education and training
  • nephrology
  • qualitative research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre : A qualitative, cognitive task analysis. / Elkhadragy, Nervana; Ifeachor, Amanda P.; Diiulio, Julie B.; Arthur, Karen J.; Weiner, Michael; Militello, Laura G.; Glassman, Peter A.; Zillich, Alan J.; Russ, Alissa L.

In: BMJ Open, Vol. 9, No. 5, e027439, 01.05.2019.

Research output: Contribution to journalArticle

Elkhadragy, Nervana ; Ifeachor, Amanda P. ; Diiulio, Julie B. ; Arthur, Karen J. ; Weiner, Michael ; Militello, Laura G. ; Glassman, Peter A. ; Zillich, Alan J. ; Russ, Alissa L. / Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre : A qualitative, cognitive task analysis. In: BMJ Open. 2019 ; Vol. 9, No. 5.
@article{0c92487aec6546ddb4200f872e04e95f,
title = "Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre: A qualitative, cognitive task analysis",
abstract = "Background Many studies identify factors that contribute to renal prescribing errors, but few examine how healthcare professionals (HCPs) detect and recover from an error or potential patient safety concern. Knowledge of this information could inform advanced error detection systems and decision support tools that help prevent prescribing errors. Objective To examine the cognitive strategies that HCPs used to recognise and manage medication-related problems for patients with renal insufficiency. Design HCPs submitted documentation about medication-related incidents. We then conducted cognitive task analysis interviews. Qualitative data were analysed inductively. Setting Inpatient and outpatient facilities at a major US Veterans Affairs Medical Centre. Participants Physicians, nurses and pharmacists who took action to prevent or resolve a renal-drug problem in patients with renal insufficiency. Outcomes Emergent themes from interviews, as related to recognition of renal-drug problems and decision-making processes. Results We interviewed 20 HCPs. Results yielded a descriptive model of the decision-making process, comprised of three main stages: detect, gather information and act. These stages often followed a cyclical path due largely to the gradual decline of patients' renal function. Most HCPs relied on being vigilant to detect patients' renal-drug problems rather than relying on systems to detect unanticipated cues. At each stage, HCPs relied on different cognitive cues depending on medication type: for renally eliminated medications, HCPs focused on gathering renal dosing guidelines, while for nephrotoxic medications, HCPs investigated the need for particular medication therapy, and if warranted, safer alternatives. Conclusions Our model is useful for trainees so they can gain familiarity with managing renal-drug problems. Based on findings, improvements are warranted for three aspects of healthcare systems: (1) supporting the cyclical nature of renal-drug problem management via longitudinal tracking mechanisms, (2) providing tools to alleviate HCPs' heavy reliance on vigilance and (3) supporting HCPs' different decision-making needs for renally eliminated versus nephrotoxic medications.",
keywords = "health and safety, medical education and training, nephrology, qualitative research",
author = "Nervana Elkhadragy and Ifeachor, {Amanda P.} and Diiulio, {Julie B.} and Arthur, {Karen J.} and Michael Weiner and Militello, {Laura G.} and Glassman, {Peter A.} and Zillich, {Alan J.} and Russ, {Alissa L.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1136/bmjopen-2018-027439",
language = "English (US)",
volume = "9",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "5",

}

TY - JOUR

T1 - Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre

T2 - A qualitative, cognitive task analysis

AU - Elkhadragy, Nervana

AU - Ifeachor, Amanda P.

AU - Diiulio, Julie B.

AU - Arthur, Karen J.

AU - Weiner, Michael

AU - Militello, Laura G.

AU - Glassman, Peter A.

AU - Zillich, Alan J.

AU - Russ, Alissa L.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Background Many studies identify factors that contribute to renal prescribing errors, but few examine how healthcare professionals (HCPs) detect and recover from an error or potential patient safety concern. Knowledge of this information could inform advanced error detection systems and decision support tools that help prevent prescribing errors. Objective To examine the cognitive strategies that HCPs used to recognise and manage medication-related problems for patients with renal insufficiency. Design HCPs submitted documentation about medication-related incidents. We then conducted cognitive task analysis interviews. Qualitative data were analysed inductively. Setting Inpatient and outpatient facilities at a major US Veterans Affairs Medical Centre. Participants Physicians, nurses and pharmacists who took action to prevent or resolve a renal-drug problem in patients with renal insufficiency. Outcomes Emergent themes from interviews, as related to recognition of renal-drug problems and decision-making processes. Results We interviewed 20 HCPs. Results yielded a descriptive model of the decision-making process, comprised of three main stages: detect, gather information and act. These stages often followed a cyclical path due largely to the gradual decline of patients' renal function. Most HCPs relied on being vigilant to detect patients' renal-drug problems rather than relying on systems to detect unanticipated cues. At each stage, HCPs relied on different cognitive cues depending on medication type: for renally eliminated medications, HCPs focused on gathering renal dosing guidelines, while for nephrotoxic medications, HCPs investigated the need for particular medication therapy, and if warranted, safer alternatives. Conclusions Our model is useful for trainees so they can gain familiarity with managing renal-drug problems. Based on findings, improvements are warranted for three aspects of healthcare systems: (1) supporting the cyclical nature of renal-drug problem management via longitudinal tracking mechanisms, (2) providing tools to alleviate HCPs' heavy reliance on vigilance and (3) supporting HCPs' different decision-making needs for renally eliminated versus nephrotoxic medications.

AB - Background Many studies identify factors that contribute to renal prescribing errors, but few examine how healthcare professionals (HCPs) detect and recover from an error or potential patient safety concern. Knowledge of this information could inform advanced error detection systems and decision support tools that help prevent prescribing errors. Objective To examine the cognitive strategies that HCPs used to recognise and manage medication-related problems for patients with renal insufficiency. Design HCPs submitted documentation about medication-related incidents. We then conducted cognitive task analysis interviews. Qualitative data were analysed inductively. Setting Inpatient and outpatient facilities at a major US Veterans Affairs Medical Centre. Participants Physicians, nurses and pharmacists who took action to prevent or resolve a renal-drug problem in patients with renal insufficiency. Outcomes Emergent themes from interviews, as related to recognition of renal-drug problems and decision-making processes. Results We interviewed 20 HCPs. Results yielded a descriptive model of the decision-making process, comprised of three main stages: detect, gather information and act. These stages often followed a cyclical path due largely to the gradual decline of patients' renal function. Most HCPs relied on being vigilant to detect patients' renal-drug problems rather than relying on systems to detect unanticipated cues. At each stage, HCPs relied on different cognitive cues depending on medication type: for renally eliminated medications, HCPs focused on gathering renal dosing guidelines, while for nephrotoxic medications, HCPs investigated the need for particular medication therapy, and if warranted, safer alternatives. Conclusions Our model is useful for trainees so they can gain familiarity with managing renal-drug problems. Based on findings, improvements are warranted for three aspects of healthcare systems: (1) supporting the cyclical nature of renal-drug problem management via longitudinal tracking mechanisms, (2) providing tools to alleviate HCPs' heavy reliance on vigilance and (3) supporting HCPs' different decision-making needs for renally eliminated versus nephrotoxic medications.

KW - health and safety

KW - medical education and training

KW - nephrology

KW - qualitative research

UR - http://www.scopus.com/inward/record.url?scp=85066865281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066865281&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2018-027439

DO - 10.1136/bmjopen-2018-027439

M3 - Article

C2 - 31129589

AN - SCOPUS:85066865281

VL - 9

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 5

M1 - e027439

ER -